July 23, 2014 3:24 AM ET

Biotechnology

Company Overview of Prexa Pharmaceuticals, Inc.

Executive Profile

Charles M. Cohen Ph.D.

Co-Founder, Chairman of The Board and Chief Executive Officer , Prexa Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 8 different industries.

See Board Relationships
63--

Background

Dr. Charles M. Cohen, known as Charlie, Ph.D. is a Co-Founder of Synthesis Capital. At Synthesis Capital, Dr. Cohen focuses on investments in private companies in the biopharmaceutical, healthcare, life science venture capital, and medical technology industries since 2003. Dr. Cohen joined Advent's healthcare and life sciences venture capital team in mid-2003. He co-founded Prexa Pharmaceuticals Inc., in August 2006 and has been its Chairman and Chief Executive Officer ...

Corporate Headquarters

184 High Street
Boston, Massachusetts 02110

United States

Phone: 617-780-1443
Fax: --

Board Members Memberships

Co Founder, Chairman of the Board and Chairman of Supervisory Board
Former Director
Former Director
1995-Present
Director, Chairman of Compensation Committee and Member of Audit Committee
1999-N/A
Former Director
2000-2005
Former Director
2004-2007
Former Director and Member of Compensation Committee
2005-N/A
Former Director and Member of Compensation Committee
2006-Present
Co-Founder, Chairman of The Board and Chief Executive Officer

Education

PhD
Harvard University
BA
University at Buffalo
PhD 1976
NYU Elaine A. and Kenneth G. Langone Medical Center
Post-Doctoral Training
University of Virginia

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Prexa Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.